BeGraft与BeGraft Plus桥接覆膜支架用于开窗和分支腔内动脉瘤修复的中期结果
本研究在两家机构纳入2018年1月至2023年7月期间接受至少一枚BeGraft或BeGraft Plus作为桥接覆膜支架的281例患者共765条目标血管,目标血管技术成功率为99.5%(761/765),1年和2年目标血管通畅率分别为98.5±0.5%和96.7±0.9%,开窗与分支之间无差异;分支组2年免于内漏和免于再干预低于开窗组,分支组不稳定率高于开窗组但通畅率相似。
要点
- 281例患者765条目标血管中,目标血管技术成功率为99.5%(761/765)。
- 1年和2年目标血管通畅率分别为98.5±0.5%和96.7±0.9%,开窗与分支无差异。
- 分支组2年免于内漏、免于再干预低于开窗组,不稳定率高于开窗组。
核心结论
- BeGraft和BeGraft Plus覆膜支架作为开窗和分支腔内动脉瘤修复中的桥接覆膜支架显示出良好的中期结果。
- 分支的不稳定率高于开窗,但分支的通畅率与开窗相似。
研究设计与样本
- 在两家机构纳入2018年1月至2023年7月期间接受至少一枚BeGraft或BeGraft Plus作为桥接覆膜支架并接受治疗和随访的患者。
- 共281例患者765条目标血管计划使用BeGraft或BeGraft Plus进行桥接。
主要发现
- 目标血管技术成功率为99.5%(761/765)。
- 1年和2年估计目标血管通畅率分别为98.5±0.5%和96.7±0.9%,开窗与分支之间无差异。
- 1年和2年估计免于目标血管相关内漏分别为98.5±0.5%和97.9±0.6%。
- 2年估计免于内漏分支组为94.2±1.9% vs 开窗组99.7±0.3%(p < .001)。
- 1年和2年估计免于目标血管相关再干预分别为97.7±0.6%和97.1±0.7%;2年时分支组93.1±2.0% vs 开窗组99.0±0.5%(p < .001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to report outcomes of the BeGraft and BeGraft Plus as bridging covered stents in fenestrated and branched endovascular aneurysm repair (FB-EVAR). METHODS: Patients treated and followed in two institutions receiving at least one BeGraft or BeGraft Plus as bridging covered stent between January 2018 and July 2023 were included. RESULTS: A total of 765 target vessels (TVs) in 281 patients were aimed to be bridged with the BeGraft or BeGraft Plus. Target vessel technical success was 99.5% (761/765). Estimated TV patency at one and two years was 98.5 ± 0.5% and 96.7 ± 0.9%, respectively, with no difference between fenestrations and branches. Estimated freedom from TV related endoleak at one and two years was 98.5 ± 0.5% and 97.9 ± 0.6%, respectively. Estimated freedom from endoleak at two years was lower for TVs targeted with branches compared with TVs targeted with fenestrations (94.2 ± 1.9% vs. 99.7 ± 0.3%, respectively; p < .001). Estimated freedom from TV related re-intervention at one and two years was 97.7 ± 0.6% and 97.1 ± 0.7%, respectively. Estimated freedom from TV related re-intervention at two years was lower for TVs targeted with branches compared with TVs targeted with fenestrations (93.1 ± 2.0% vs. 99.0 ± 0.5%, respectively; p < .001). Estimated freedom from TV instability at one and two years was 96.8 ± 0.7% and 94.5 ± 1.1%, respectively. Estimated freedom from TV instability at two years was 96.0 ± 1.3% for fenestrations and 91.2 ± 2.2% for branches (p = .003). CONCLUSION: The BeGraft and BeGraft Plus covered stents showed good midterm outcomes as bridging covered stents in FΒ-EVAR. Branches showed higher instability rates compared with fenestrations. Branches showed similar patency rates to fenestrations.
引用
- Katsargyris A, Hasemaki N, Abu Jiries M, et al. Midterm Outcomes of the BeGraft and BeGraft Plus Bridging Covered Stents for Fenestrated and Branched Endovascular Aneurysm Repair. Eur J Vasc Endovasc Surg. 2024. PMID: 39515513. doi:10.1016/j.ejvs.2024.10.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。